Loss of neurofibromatosis 1 (NF1) gene expression in NF1‐associated pilocytic astrocytomas

D. H. Gutmann , J. Donahoe , T. Brown , C. D. James
Neuropathology and Applied Neurobiology 26 ( 4) 361 -367

136
2000
Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations

W. Liu , D. I. Smith , K. J. Rechtzigel , S. N. Thibodeau
Nucleic Acids Research 26 ( 6) 1396 -1400

264
1998
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.

D. H. Gutmann , C. D. James , M. Poyhonen , D. N. Louis
Neurology 61 ( 10) 1397 -1400

63
2003
Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.

J. Li , A. Perry , C. D. James , D. H. Gutmann
Neurology 56 ( 7) 885 -890

52
2001
Pleiotropic role for MYCN in medulloblastoma

F. J. Swartling , M. R. Grimmer , C. S. Hackett , P. A. Northcott
Genes & Development 24 ( 10) 1059 -1072

138
2010
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics

X. Huang , A. M. Dubuc , R. Hashizume , J. Berg
Genes & Development 26 ( 16) 1780 -1796

80
2012
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

K.-M. Chan , D. Fang , H. Gan , R. Hashizume
Genes & Development 27 ( 9) 985 -990

597
2013
Gene and chromosomal alterations associated with the development of human gliomas.

V. P. Collins , C. D. James
The FASEB Journal 7 ( 10) 926 -930

95
1993
EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma

Q.-W. Fan , C. Cheng , Z. A. Knight , D. Haas-Kogan
Science Signaling 2 ( 55)

205
2009
Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma

Q.-W. Fan , C. Cheng , C. Hackett , M. Feldman
Science Signaling 3 ( 147)

331
2010
Immunohistochemical detection of EGFRvIII and prognostic significance in patients with malignant glioma enrolled in NCCTG clinical trials

J. C. Buckner , K. D. Aldape , K. Ballman , B. W. Scheithauer
Journal of Clinical Oncology 22 1508 -1508

8
2004
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer

D. A. Solomon , T. Kim , L. A. Diaz-Martinez , J. Fair
Science 333 ( 6045) 1039 -1043

329
2011
Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease.

J. Qi , D. R. Esfahani , T. Huang , P. Ozark
Acta neuropathologica communications 7 ( 1) 75

13
2019
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review

G. Kaur , E. T. Sayegh , A. Larson , O. Bloch
Neuro-oncology 16 ( 5) 628 -636

120
2014
EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Charlotte Aaberg-Jessen , Louise Fogh , Bo Halle , Vibeke Jensen
Neuro-oncology 15

2
2013
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing

R. Hashizume , N. Gupta , M. S. Berger , A. Banerjee
Neuro-oncology 12 ( 4) 366 -376

21
2010
4
2010
Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors

I. Park , P. E. Z. Larson , M. L. Zierhut , S. Hu
Neuro-oncology 12 ( 2) 133 -144

142
2010
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide

G. Prasad , T. Sottero , X. Yang , S. Mueller
Neuro-oncology 13 ( 4) 384 -392

131
2011